214
Views
10
CrossRef citations to date
0
Altmetric
Articles

Analysis of measured values of ejaculation time in healthy males

, &
Pages 25-28 | Published online: 14 Jan 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Muammer Kendirci, Emad Salem & Wayne JG Hellstrom. (2007) Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation. Therapeutics and Clinical Risk Management 3:2, pages 277-289.
Read now
Guy Grenier & E. Sandra Byers. (2001) Operationalizing premature or rapid ejaculation. The Journal of Sex Research 38:4, pages 369-378.
Read now
David Goldmeier. (1999) Letter to Editor. Sexual and Marital Therapy 14:1, pages 91-92.
Read now

Articles from other publishers (6)

Juza Chen, Gal Keren-Paz, Yuval Bar-Yosef & Haim Matzkin. (2007) The Role of Phosphodiesterase Type 5 Inhibitors in the Management of Premature Ejaculation: A Critical Analysis of Basic Science and Clinical Data. European Urology 52:5, pages 1331-1339.
Crossref
Hilde Vanden Broucke, Karel Everaert, Wim Peersman, Hubert Claes, Dirk Vanderschueren & Marijke Van Kampen. (2007) Ejaculation Latency Times and Their Relationship to Penile Sensitivity in Men With Normal Sexual Function. Journal of Urology 177:1, pages 237-240.
Crossref
W. F. Wang, S. Minhas & D. J. Ralph. (2006) Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. International Journal of Andrology 29:5, pages 503-509.
Crossref
R T Segraves. (2006) Rapid ejaculation: a review of nosology, prevalence and treatment. International Journal of Impotence Research 18:S1, pages S24-S32.
Crossref
R.J. Levin. (2004) Round Table: Ejaculatory Disorders: L16: Measuring and Quantifying Ejaculation in the Laboratory. The Journal of Sexual Medicine 1, pages 17-19.
Crossref
Ibrahim A Abdel-Hamid. (2004) Phosphodiesterase 5 Inhibitors in Rapid Ejaculation. Drugs 64:1, pages 13-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.